Oryzon Genomics reduces losses by 20.7% in 2023, reporting over 3.3 million euros compared to the previous year's 4.2 million. Income falls by nearly 28%, standing...
The Spanish company, Laminar Pharma, which emerged from the University of the Balearic Islands, is preparing to go public at the end of 2020. In order...